Adam C. Fisher, PhD

FDA is anticipating how AI may advance manufacturing and improve supply chain security.

FDA is anticipating how AI may advance manufacturing and improve supply chain security.

Some manufacturers are developing smaller, more mobile drug manufacturing processes for point-of-use patient care.

FDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.